Zobrazeno 1 - 8
of 8
pro vyhledávání: '"J Myles Keck"'
Publikováno v:
Drugs in Context, Vol 11, Pp 1-23 (2023)
Invasive fungal infections are a strong contributor to healthcare costs, morbidity and mortality, especially amongst hospitalized patients. Historically, Candida was responsible for approximately 15% of all nosocomial bloodstream infections. In the p
Externí odkaz:
https://doaj.org/article/1daaba8752184cbb968e8798b6922b10
Autor:
J. Myles Keck, Mary Joyce B. Wingler, David A. Cretella, Prakhar Vijayvargiya, Jamie L. Wagner, Katie E. Barber, Tulip A. Jhaveri, Kayla R. Stover
Publikováno v:
Therapeutic Advances in Infectious Disease, Vol 9 (2022)
Febrile neutropenia (FN) is associated with mortality rates as high as 40%, highlighting the importance of appropriate clinical management in this patient population. The morbidity and mortality of FN can be attributed largely to infectious processes
Externí odkaz:
https://doaj.org/article/41dfca69a4514510b060cb04906e65f3
Publikováno v:
Journal of Cannabis Research, Vol 3, Iss 1, Pp 1-7 (2021)
Abstract Cannabidiol and related cannabinoids are under exploration for the treatment of a number of disease states. The cannabinoid-quinone HU-331 has been studied as a potential anticancer therapeutic. Previous studies provide evidence that HU-331
Externí odkaz:
https://doaj.org/article/c8b39dea68fd4341a7756986547d99b1
Autor:
J. Myles Keck, David A. Cretella, Kayla R. Stover, Jamie L. Wagner, Katie E. Barber, Tulip A. Jhaveri, Prakhar Vijayvargiya, Zerelda Esquer Garrigos, Mary Joyce B. Wingler
Publikováno v:
Antibiotics
Volume 12
Issue 2
Pages: 193
Volume 12
Issue 2
Pages: 193
Delays in the treatment of proven invasive fungal disease have been shown to be harmful. However, empiric treatment for all patients at risk of infection has not demonstrated benefit. This study evaluates the effects of a micafungin stewardship initi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e40e618e1d3d5709f648220a361c755
https://doi.org/10.3390/antibiotics12020193
https://doi.org/10.3390/antibiotics12020193
Publikováno v:
Journal of Cannabis Research
Journal of Cannabis Research, Vol 3, Iss 1, Pp 1-7 (2021)
Journal of Cannabis Research, Vol 3, Iss 1, Pp 1-7 (2021)
Cannabidiol and related cannabinoids are under exploration for the treatment of a number of disease states. The cannabinoid-quinone HU-331 has been studied as a potential anticancer therapeutic. Previous studies provide evidence that HU-331 displays
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a6ef0b1223404856a610ed568317b27
https://pubmed.ncbi.nlm.nih.gov/33892826
https://pubmed.ncbi.nlm.nih.gov/33892826
Publikováno v:
Open Forum Infectious Diseases
Background Limited literature exists to guide the appropriate antimicrobial choice, dose, and duration for Stenotrophomonas maltophilia (S. maltophilia) pneumonia. Methods This multi-center, retrospective cohort study was conducted in adults diagnose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eeadb0b110e6219e8c100c317ee08873
http://europepmc.org/articles/PMC8643906
http://europepmc.org/articles/PMC8643906
Autor:
Xiaohua Jiang, Jennifer D Conner, James T. Wilson, Joseph E. Deweese, J. Myles Keck, Edward C. Lisic
Publikováno v:
Chemical research in toxicology. 32(10)
Topoisomerase II is a nuclear enzyme involved in the maintenance of DNA and is an effective anticancer drug target. However, several clinical topoisomerase II-targeted agents display significant off-target toxicities and adverse events. Thus, it is i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e748a954bf1442e76900b4887f686c15
https://pubmed.ncbi.nlm.nih.gov/31512855
https://pubmed.ncbi.nlm.nih.gov/31512855
Autor:
J. Myles Keck, Alina Viteri, Jacob Schultz, Rebecca Fong, Charles Whitman, Madeline Poush, Marlee Martin
Publikováno v:
Antibiotics, Vol 13, Iss 7, p 648 (2024)
Antimicrobial resistance is a global threat that requires urgent attention to slow the spread of resistant pathogens. The United States Centers for Disease Control and Prevention (CDC) has emphasized clinician-driven antimicrobial stewardship approac
Externí odkaz:
https://doaj.org/article/48431ba9752f4e20a5b343a24b645628